Could a simple pain shot improve IVF recovery without hurting success?
NCT ID NCT07185724
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving the painkiller ketorolac after egg retrieval can safely reduce pain without lowering the chance of pregnancy in fresh embryo transfers. About 200 IVF patients will be randomly assigned to receive either ketorolac or no ketorolac after their egg retrieval. The researchers will compare implantation rates, pain levels, and live birth rates between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ketorolac (a nonsteroidal anti-inflammatory drug given by IV)
- What this could lead to
- If it works, this could show that ketorolac is a safe and effective painkiller for women having fresh embryo transfers after egg retrieval.
- What could go wrong
- This is a single, mid-sized trial. Earlier studies were mixed, and there is still a theoretical risk that ketorolac could affect implantation or increase bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2025
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 37 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * IVF utilizing autologous oocytes and all sperm sources * IVF cycles utilizing ICSI and standard insemination * Plan to transfer embryo on day 5 * BMI below 50 Exclusion Criteria: -allergies or medical contraindications to NSAIDs
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fresh embryo transfer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UI Health Care Center for Advanced Reproductive Care
RECRUITINGIowa City, Iowa, 52245, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.